WASHINGTON, Sept. 2 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Reliance Life Sciences Private Limited from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Santhosh Mathai, Business Head-Pharmaceuticals, Reliance Life Sciences Private Limited, Dhirubhai Ambani Life Sciences Centre R-282 Ttc Area of MIDC, Thane Belapur Road, Rabale, Navi Mumbai 400701 Maharashtra, India, (b)(6)< . . .

Click here for more information about our products